Altimmune Inc (ALT)

Add to Watchlists
Create an Alert
2.96 -0.07  -2.31% NASDAQ Mar 21, 11:47 Delayed 2m USD
View Full Chart
ALT Price Chart
View All Events

ALT Events

Date Type Description
09/14/2018 Splits Ratio: 333333:10000000
08/10/2018 Misc Altimmune Inc Second Quarter Earnings Conference Call in 2018
View All Performance Charts

ALT Total Returns Comparison


ALT One Page Reports



  • URL:
  • Investor Relations URL:
  • HQ State/Province: Maryland
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Value
  • Next Earnings Release: N/A
  • Last Earnings Release: Mar. 14, 2018
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: Jan. 20, 2017
  • Description: Altimmune Inc is a clinical stage immunotherapeutic biotechnology company. It is involved in the business of developing products that engage, stimulate and improve immune responses for the prevention and treatment of diseases. The firm's product candidates include Nasovax, Heptcell, Sparvax-L, Nasoshield, and Oncosyn. It also develops platform technologies such as RespirVec and Densigen. The company generates its revenue from cost plus fee contracts and fixed-price contracts.

ALT Comparables


ALT Excel Add-In Codes

  • Name: =YCI("ALT","name")
  • Description: =YCI("ALT","description")
  • Sector: =YCI("ALT","sector")
  • Industry: =YCI("ALT","industry")
  • Est. Current Fiscal Year End: =YCI("ALT","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.




Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.